COLL

Collegium Pharmaceutical, Inc.

COLL · CIK 1267565 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$205M
20182025
Net Income$17M
20182025
Operating CF$329M
20182025
Free Cash Flow$328M
20182025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Revenue$0.2B$0.2B$0.1B$0.1B$0.0B$0.1B$0.1B$0.1B
Cost of Revenue$0.1B$0.1B$0.1B$0.1B$0.0B$0.0B$0.0B$0.0B
Gross Profit$0.1B$0.1B$0.1B$0.0B$-0.0B$0.0B——
R&D Expense$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
SG&A Expense$0.1B$0.1B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Operating Income$0.1B$0.0B$0.1B$0.0B$-0.0B$0.0B$-0.0B$0.0B
Net Income$0.0B$0.0B$0.0B$-0.0B$-0.0B$0.0B$-0.0B$0.0B
EPS (Basic)$0.54$0.39$0.99$-0.21$-0.73$0.20$0.27$0.27
EPS (Diluted)$0.46$0.36$0.82$-0.21$-0.73$0.20$0.27$0.27

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Total Assets$1.7B$1.7B$1.1B$1.2B$0.7B$0.6B$0.3B$0.3B
Current Assets$0.7B$0.5B$0.5B$0.4B$0.3B$0.3B$0.3B$0.2B
Cash & Equivalents$0.2B$0.1B$0.2B$0.2B$0.2B$0.2B$0.2B$0.1B
Total Liabilities$1.4B$1.4B$0.9B$1.0B$0.5B$0.5B$0.2B$0.2B
Current Liabilities$0.4B$0.5B$0.5B$0.4B$0.3B$0.2B$0.2B$0.2B
Stockholders' Equity$0.3B$0.2B$0.2B$0.2B$0.2B$0.2B$0.1B$0.1B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Operating Cash Flow$0.3B$0.2B$0.3B$0.1B$0.1B$0.1B$0.0B$0.2B
Investing Cash Flow$-0.1B$-0.3B$-0.1B$-0.6B$-0.0B$-0.4B$-0.0B$-0.0B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$-0.1B$-0.1B$-0.1B$0.4B$-0.1B$0.3B$0.0B$-0.1B
← Companies